# Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

> **NCT00569283** · PHASE1 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 18 (estimated)

## Conditions studied

- Cancer

## Interventions

- **BIOLOGICAL:** therapeutic allogeneic lymphocytes

## Key facts

- **NCT ID:** NCT00569283
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2013-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00569283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00569283, "Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00569283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*